Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Suicide risk in hepatitis C and during interferon-alpha therapy: a review and clinical update.

Sockalingam S, Links PS, Abbey SE.

J Viral Hepat. 2011 Mar;18(3):153-60. doi: 10.1111/j.1365-2893.2010.01393.x. Epub 2010 Nov 10. Review.

PMID:
21070503
2.

[Hepatitis C, interferon a and depression: main physiopathologic hypothesis].

Vignau J, Karila L, Costisella O, Canva V.

Encephale. 2005 May-Jun;31(3):349-57. Review. French.

PMID:
16142050
3.

Psychiatric problems in patients infected with hepatitis C before and during antiviral treatment with interferon-alpha: a review.

Quelhas R, Lopes A.

J Psychiatr Pract. 2009 Jul;15(4):262-81. doi: 10.1097/01.pra.0000358313.06858.ea. Review.

PMID:
19625882
4.

A review of sleep disturbance in hepatitis C.

Sockalingam S, Abbey SE, Alosaimi F, Novak M.

J Clin Gastroenterol. 2010 Jan;44(1):38-45. doi: 10.1097/MCG.0b013e3181b314ea. Review.

PMID:
19730115
6.

Interferon alfa in the treatment of chronic viral hepatitis B and C.

Woo MH, Burnakis TG.

Ann Pharmacother. 1997 Mar;31(3):330-7. Review.

PMID:
9066942
7.

Treatment options for patients with hepatitis C: role of pharmacists in optimizing treatment response and managing adverse events.

Smith JP.

Pharmacotherapy. 2008 Sep;28(9):1151-61. doi: 10.1592/phco.28.9.1151. Review.

PMID:
18752386
8.
9.

Oromucosal Administration of Interferon to Humans.

Beilharz MW, Cummins MJ, Bennett AL, Cummins JM.

Pharmaceuticals (Basel). 2010 Jan 28;3(2):323-344. Review.

Supplemental Content

Support Center